Arthritis & Rheumatology is an esteemed journal that serves as an official publication of the American College of Rheumatology. This peer-reviewed journal primarily caters to both scientists and clinicians deeply involved in understanding the natural history, pathophysiology, treatment, and outcomes of rheumatic diseases.
The journal’s long-standing reputation can be traced through its numerous volumes, including the recent ones from 2022 – Volume 74 to 2023 – Volume 75. Their special issue, “ACR Convergence 2023 Abstract Supplement“, offers a comprehensive look at contemporary research and findings in the realm of rheumatology.
Key articles from the journal shed light on various aspects of the field:
“Endothelial Cell–Activating Antibodies in COVID-19” delves into the implications of COVID-19 on rheumatic diseases, with contributors like Hui Shi, Yogendra Kanthi, and others.
The article on “Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease” provides insights into the challenges faced by patients treated with low-dose glucocorticoids and the prevention strategies through anti-osteoporosis medications.
“Pregnancy Outcomes in Women With Psoriatic Arthritis” studies the repercussions of antirheumatic treatment timings and their impact on pregnancy.
The journal’s commitment to quality can also be gauged by its impact score. In 2022, Arthritis and Rheumatology secured an impact score of 6.63, as computed in 2023. Although there was a slight dip compared to 2021, the journal continues to be a robust platform for insights and research dissemination.
To conclude, Arthritis & Rheumatology stands as a beacon for those desiring a deeper grasp on the complexities of rheumatic diseases, with its rich tapestry of articles, research papers, and special issues.
